ONS-5010 demonstrated to be non-inferior to Lucentis at 12 weeksBLA resubmission on track for calendar Q1 2025Entered into agreements for warrant ...
Aescuvest Capital Partners (ACP) is at the forefront of Healthtech investing, leveraging its deep expertise in European ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback